Hi — I handle bulk & wholesale for this oil. Ask me anything, or tap a question below.
What the research says
More than a carrier. And we cite every word.
People reach for Walnut for more than one thing. Here’s what the published studies actually found — graded honestly, each one linked.
11
uses studied
16
papers cited
0
hidden from you
What the published studies found
Early evidence · 2 studies
Acne
Two in-vitro studies show that Juglans regia (walnut) leaf and husk extracts inhibit Propionibacterium acnes and other acne-associated bacteria, with inhibition zones exceeding tea tree oil in one study and very low MICs in the other. However, no human clinical trials exist, and neither study tested walnut oil itself—only leaf/husk extracts, with the husk tested as part of a multi-plant blend.
Two small cosmetic formulation studies evaluated emulsions made from enzymatically interesterified mutton tallow–walnut oil blends in human volunteer panels (n=83 and n=78), reporting good skin moisturization and sensory ratings, with one study proposing potential use for atopic dermatitis-prone skin. However, these were uncontrolled sensory/moisturization evaluations of chemically modified fat blends, not clinical trials of walnut oil itself for dry skin, so any moisturizing effect cannot be attributed to walnut oil alone.
One RCT (n=360 eczema patients) found topical formulations of walnut combined with Indian pennywort and turmeric improved erythema, oedema, itching, scaling and lichenification versus placebo, but because walnut was tested only as part of a multi-herb blend its individual contribution cannot be determined. A separate case report documented ulceronecrotic lesions and sepsis in an infant with atopic dermatitis after application of a homemade walnut cream.
The only relevant evidence is in-vitro/agricultural: walnut green husk extracts and juglone inhibited plant-pathogenic fungi (Alternaria, Botrytis, Fusarium, Phytophthora) and a bee pathogen, and walnut leaf powder suppressed Fusarium corm rot in saffron. No human clinical trials exist evaluating walnut oil against human fungal infections (e.g., candidiasis, tinea, onychomycosis).
No clinical trials have tested walnut oil for treating rash or contact dermatitis. The only directly relevant study is a cosmetic formulation/sensory evaluation of a walnut oil-based emulsion proposed (but not clinically tested) for atopic dermatitis prevention; the other relevant finding is an RCT noting that oral walnut can cause rash and pruritus as side effects.
The only relevant study identified in the provided results is a 2026 mouse study (PMID 42255691) showing oral walnut oil unsaponifiable matter mitigated D-galactose-induced aging-related liver injury via the gut-liver axis; it addresses internal/liver aging in animals, not skin aging or wrinkles in humans. No human clinical trials, RCTs, or topical dermatology studies on wrinkles were found in the provided results.
Only one relevant study was identified: a 2025 preclinical study showing that decellularized Persian walnut leaf (Juglans regia) scaffolds accelerated wound closure, collagen deposition, and epithelial thickness in a mouse excisional wound model. No human clinical trials—and no studies of walnut oil itself—for burns or wound healing were found among the results (one retrieved article was a false positive matching 'Walnut St' in an author's address).
The identifiable evidence is preclinical only: a 2022 study (PMID 35422870) showed that Juglans regia (walnut) leaf extracts reduced arthritis scores, paw edema, and pro-inflammatory markers (TNF-α, NF-κB, IL-6, IL-1β, COX-2, PGE2) in rodent models of arthritis and acute inflammation. No human clinical trials of walnut for joint inflammation were identified, and the studied preparation was a leaf extract, not walnut oil.
The only relevant study found is a preclinical mouse study of Juglans regia (walnut) LEAF extracts (not walnut oil) showing antinociceptive and anti-inflammatory effects at very high intraperitoneal doses (1-3 g/kg); no human clinical trials of walnut oil for muscle pain exist. Notably, one retrieved article (PMID 20797917) is an irrelevant false match—it concerns topical ibuprofen in rats and matched only because the authors' address contains 'Walnut Hill Lane.'.
The only identified study is a cosmetic formulation study of emulsions made from enzymatically interesterified mutton tallow and walnut oil, tested for stability, particle characteristics, and sensory/moisturizing properties in 78 healthy respondents. Psoriasis was mentioned only speculatively as a potential target application; no clinical efficacy testing in psoriasis patients was performed.
The only identifiable relevant publication is a 2025 narrative review (Foods) listing walnut (Juglans regia) among several foods 'purported' to improve sleep—via GABAergic and serotonergic mechanisms—based largely on preclinical evidence; the authors themselves conclude further research is needed. No randomized controlled trials or human clinical studies testing walnut specifically for insomnia were found, and the evidence pertains to dietary walnut consumption, not walnut essential oil.
